Surgery vs. chemoradiotherapy in the treatment of locally advanced squamous cell carcinoma of the hypopharynx – survival analysis and prognostic factors

Authors

  • Luís André Baptista CHLO https://orcid.org/0009-0008-3475-0308
  • Mariana Cardoso Unidade Local de Saúde de Lisboa Norte, Lisboa, Portugal
  • Carolina Arede Unidade Local de Saúde de Lisboa Central, Lisboa, Portugal
  • Filipe Jacinto Unidade Local de Saúde do Algarve, Algarve, Portugal
  • Margarida Pereira Instituto Português de Oncologia, Lisboa, Portugal
  • Joana Guincho Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal
  • Beatriz Rodrigues Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal
  • Carlota Sousa Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal
  • Sara Ramalho Instituto Português de Oncologia, Lisboa, Portugal
  • Pedro Montalvão Instituto Português de Oncologia, Lisboa, Portugal
  • Pedro Escada Unidade Local de Saúde de Lisboa Ocidental, Lisboa, Portugal
  • Miguel Magalhães Instituto Português de Oncologia, Lisboa, Portugal

DOI:

https://doi.org/10.34631/sporl.3118

Keywords:

Surgery, Chemoradiotherapy, Squamous cell carcinoma, Hypopharynx, Overall survival, Disease-free survival, Organ-preserving treatment

Abstract

This unicentric retrospective observational study analyzed 132 individuals with squamous cell carcinoma of the hypopharynx in T3 and T4a stages, diagnosed between 2017 and 2021, with the aim of comparing survival outcomes in individuals treated with initial surgery vs. definitive chemoradiotherapy (CRT) and determining prognostic predictors. The median follow-up time was 31.5 months, with a median age of 61 years. No significant differences were found in overall survival (OS) (49.3% vs. 46.5%, p=0.912) or disease-free survival (DFS) (57.8% vs. 56.6%, p=0.646) between the treatment types. T and N classifications were independent predictors of OS. The study suggests that the type of initial treatment does not substantially affect prognosis in this patient group.

Downloads

Download data is not yet available.

References

Mendenhall WM, Pfister DG. Treatment of head and neck cancers. In: DeVita, Hellman, Rosenberg's. Cancer: Principles and Practice of Oncology. 7th ed. Lippincott Williams & Wilkins, editor. Philadelphia; 2005. 732 p.

Mousavi SE, Ilaghi M, Mirzazadeh Y, Mosavi Jarrahi A, Nejadghaderi SA. Global epidemiology and socioeconomic correlates of hypopharyngeal cancer in 2020 and its projection to 2040: findings from GLOBOCAN 2020. Front Oncol. 2024 Sep 2:14:1398063. doi: 10.3389/fonc.2024.1398063.

Chen YY, Tsai YT, Tsai MS, Hsu CM, Lai CH, Lu CH. et al. Treatment outcomes of locally advanced hypopharyngeal squamous cell carcinoma. Ther Radiol Oncol. 2018; 2:17. doi: 10.21037/tro.2018.

Lo WC, Wu CT, Wang CP, Yang TL, Lou PJ, Ko JY. et al. Lymph node ratio predicts recurrence and survival for patients with resectable stage 4 hypopharyngeal cancer. Ann Surg Oncol. 2017 Jun;24(6):1707-1713. doi: 10.1245/s10434-017-5770-1.

Reis I, Aguiar A, Alzamora C, Ferreira C, Castro V, Soares A. et al. Carcinoma espinocelular da hipofaringe: resultados de uma instituição numa coorte de doentes tratados com intenção curativa com ou sem preservação da laringe. Radiol Bras. 2016 Jan-Feb;49(1):21-5. doi: 10.1590/0100-3984.2015.0018.

Tsai TY, Yap WK, Wang TH, Lu YA, See A, Hu YF. et al. Upfront surgery versus upfront concurrent chemoradiotherapy as primary modality in hypopharyngeal squamous cell carcinoma: a systematic review and meta-analysis. J Otolaryngol Head Neck Surg. 2024 Jan-Dec:53:19160216241293633. doi: 10.1177/19160216241293633.

Zheng L, Fang S, Ye L, Cai W, Xiang W, Qi Y. et al. Optimal treatment strategy and prognostic analysis for hypopharyngeal squamous-cell carcinoma patients with T3-T4 or node-positive: a population-based study. Eur J Surg Oncol. 2023 Jul;49(7):1162-1170. doi: 10.1016/j.ejso.2023.03.215.

Cordunianu AGV, Ganea G, Cordunianu MA, Cochior D, Moldovan CA, Adam R. Hypopharyngeal cancer trends in a high-incidence region: a retrospective tertiary single center study. World J Clin Cases. 2023 Aug 26;11(24):5666-5677. doi: 10.12998/wjcc.v11.i24.5666.

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.

Cui J, Wang L, Piao J, Huang H, Chen W, Chen Z. et al. Initial surgical versus non-surgical treatments for advanced hypopharyngeal cancer: a meta-analysis with trial sequential analysis. Int J Surg. 2020 Oct:82:249-259. doi: 10.1016/j.ijsu.2020.04.059.

Szuecs M, Kuhnt T, Punke C, Witt G, Klautke G, Kramp B. et al. Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer. J Radiat Res. 2015 Jan;56(1):159-68. doi: 10.1093/jrr/rru093J

Xiao JB, Cherukupalli A, Tran KL, Prisman E. Predictors of gastrostomy tube placement in head and neck cancer patients undergoing radiation or chemoradiotherapy: a systematic review. Head Neck. 2025 Mar;47(3):1006-1017. doi: 10.1002/hed.28010.

Published

2025-12-12

How to Cite

Baptista, L. A., Cardoso, M., Arede, C., Jacinto, F., Pereira, M., Guincho, J., … Magalhães, M. (2025). Surgery vs. chemoradiotherapy in the treatment of locally advanced squamous cell carcinoma of the hypopharynx – survival analysis and prognostic factors. Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery, 63(4), 391–399. https://doi.org/10.34631/sporl.3118

Issue

Section

Original Article